Staphylococcus aureus News and Research

RSS

Staphylococcus aureus is a spherical bacterium (coccus) which on microscopic examination appears in pairs, short chains, or bunched, grape-like clusters. These organisms are Gram-positive. Some strains are capable of producing a highly heat-stable protein toxin that causes illness in humans.

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel anti-infectives and immunotherapies for infectious diseases, announced today that the U.S. Food and Drug Administration has accepted its Investigational New Drug (IND) application for AR-301, also referred to as Salvecin, the company's fully human anti-Staphylococcal α-toxin IgG1 monoclonal antibody being developed for the treatment of hospital-acquired and ventilator-associated pneumonia (HAP and VAP) caused by Staphylococcus aureus, including multi-drug resistant 'MRSA' strains.

8 Jul 2015

Aridis' Aerucin gets FDA Fast Track Designation for treatment of hospital-acquired and ventilator-associated pneumonia

Aridis Pharmaceuticals, Inc., a biopharmaceutical company applying proprietary technologies to produce novel therapies for infectious diseases, announced today that the U.S. Food and Drug Administration granted Fast Track Designation to its fully human monoclonal antibody Aerucin for the treatment of hospital-acquired and ventilator-associated pneumonia caused by Pseudomonas aeruginosa.

30 Jun 2015

Kenall Manufacturing introduces light fixture to kill harmful bacteria linked to HAIs

Kenall Manufacturing today introduced Indigo-Clean, a light fixture that uses Continuous Environmental Disinfection technology to continuously kill harmful bacteria linked to hospital acquired infections (HAIs). The technology behind Indigo-Clean inactivates a wide range of micro-organisms that are known causes of HAIs, including MRSA (Methicillin-resistant Staphylococcus aureus), C.difficile and VRE (Vancomycin-resistant Enterococcus).

27 Jun 2015

Daily CHG bathing protocol for pediatric patients reduces bloodstream infections by 59%: Study

Daily bathing of pediatric patients with disposable cloths containing 2 percent chlorhexidine gluconate (CHG) reduced central line-associated bloodstream infections (CLABSIs) by 59 percent and saved approximately $300,000 in one hospital over a six-month period, according to a new study.

27 Jun 2015

World MRSA Day Kickoff Event and Global C. difficile Summit to be held on September 26, 2015 in Illinois

Methicillin-resistant Staphyloccocus aureus (MRSA), the antibiotic resistant form of Staphylococcus aureus is rampant in U.S. healthcare facilities, in the community, in livestock and in the environment.

25 Jun 2015

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

Basilea Pharmaceutica AG today announces the UK launch of its broad-spectrum Cephalosporin Zevtera (Ceftobiprole medocaril) for the first-line treatment of serious bacterial pneumonia.

25 Jun 2015

Dipexium Pharmaceuticals intends to sell common stock in underwritten public offering

Dipexium Pharmaceuticals, Inc., a late stage pharmaceutical company focused on the development and commercialization of Locilex (pexiganan cream 0.8%), today announced it intends to offer and sell common stock in an underwritten public offering.

25 Jun 2015

Survey finds first evidence of MRSA in sausages, minced pork from supermarkets in the UK

A survey carried out earlier this year has found the first evidence of the 'superbug' bacteria Methicillin-Resistant Staphylococcus aureus (MRSA) in sausages and minced pork obtained from supermarkets in the UK. However, researchers stress that this does not pose a significant immediate risk to the public.

19 Jun 2015

Study suggests new strategies to stop spread of Staph infections

Staphylococcus aureus -- better known as Staph -- is a common inhabitant of the human nose, and people who carry it are at increased risk for dangerous Staph infections.

7 Jun 2015

AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification

AmpliPhi’s commissioned its production facility in early 2014 after conducting a comprehensive evaluation of global manufacturing options...

4 Jun 2015

Simple pre-surgical intervention can reduce S aureus surgical site infections

Implementation of a pre-surgical intervention that included screening for the bacteria Staphylococcus aureus, treating patients who were positive for this bacteria, and the administration of antibiotics based on these culture results was associated with a modest reduction in S aureus surgical site infections, according to a study in the June 2 issue of JAMA.

3 Jun 2015

Stable IV formulation to treat systemic susceptible and resistant Gram-positive hospital-acquired infections

MGB Biopharma, a biopharmaceutical company developing a truly novel class of anti-infectives, to address the major global problem of antibiotic resistance - announces that it has developed a stable intravenous (IV) formulation of MGB-BP-3, designed for the treatment of systemic susceptible and resistant Gram-positive hospital-acquired infections.

2 Jun 2015

Chronic exposure to bacteria may lead to development of Type 2 diabetes

Bacteria and viruses have an obvious role in causing infectious diseases, but microbes have also been identified as the surprising cause of other illnesses, including cervical cancer (Human papilloma virus) and stomach ulcers (H. pylori bacteria).

2 Jun 2015

Scientists study active substance against dreaded hospital pathogen Staphylococcus aureus

In the German Center for Infection Research (DZIF), scientists from the universities of Tübingen, Münster and Munich join forces and prepare together with the company Hyglos clinical studies on an active substance against the dreaded hospital pathogen Staphylococcus aureus: A highly effective protein from bacteria-specific viruses, so-called bacteriophages, shall rapidly kill the bacteria, which frequently occur in the nose.

30 May 2015

Healthcare workers serve as vector for MRSA transmission in nursing home settings

Healthcare workers frequently contaminate their gloves and gowns during every day care of nursing homes residents with drug resistant Staphylococcus aureus or MRSA, according to a new study. The findings were published online today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

29 May 2015

DigiPath, Euphoria partner to set highest medical marijuana patient safety and education standards

DigiPath Labs of Las Vegas, a subsidiary of DigiPath, Inc., has entered into a one-year agreement with Euphoria Wellness to conduct comprehensive safety and potency tests on the products Euphoria will sell in its Las Vegas medical marijuana dispensary.

28 May 2015

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Roche announced today that the US Food and Drug Administration has provided 510(k) clearance for the cobas Cdiff Test to detect Clostridium difficile (C. difficile) in stool specimens.

26 May 2015

Bathing patients in common hospital soap can reduce MRSA contamination

Holding hope for a relatively inexpensive way to improve care and prevent the spread of deadly hospital-acquired infections, a new study reports that bathing patients in a common hospital soap, called chlorhexidine, was equally effective in preventing the transmission of the methicillin-resistant Staphylococcus aureus (MRSA) as the common practice of having healthcare workers avoid physical contact with the patients.

14 May 2015

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

A fecal microbiota transplant (FMT) not only cured a case of Clostridium difficile (C. diff) infection in a 66 year old man; it eliminated populations of multi-drug resistant organisms both in the patient's gastrointestinal tract, and several other body sites.

7 May 2015

New device can turn smartphone into DNA-scanning fluorescent microscope

If you thought scanning one of those strange, square QR codes with your phone was somewhat advanced, hold on to your seat. Researchers at the University of California, Los Angeles have recently developed a device that can turn any smartphone into a DNA-scanning fluorescent microscope.

30 Apr 2015

Staphylococcus aureus News and Research

Further Reading

Aridis expands, accelerates current AR-301 Phase 2a study for treatment of acute pneumonia in the U.S.

Aridis' Aerucin gets FDA Fast Track Designation for treatment of hospital-acquired and ventilator-associated pneumonia

Kenall Manufacturing introduces light fixture to kill harmful bacteria linked to HAIs

Daily CHG bathing protocol for pediatric patients reduces bloodstream infections by 59%: Study

World MRSA Day Kickoff Event and Global C. difficile Summit to be held on September 26, 2015 in Illinois

Basilea announces UK launch of broad-spectrum Cephalosporin Zevtera for first-line treatment of pneumonia

Dipexium Pharmaceuticals intends to sell common stock in underwritten public offering

Survey finds first evidence of MRSA in sausages, minced pork from supermarkets in the UK

Study suggests new strategies to stop spread of Staph infections

AmpliPhi’s bacteriophage manufacturing facility receives cGMP certification

Simple pre-surgical intervention can reduce S aureus surgical site infections

Stable IV formulation to treat systemic susceptible and resistant Gram-positive hospital-acquired infections

Chronic exposure to bacteria may lead to development of Type 2 diabetes

Scientists study active substance against dreaded hospital pathogen Staphylococcus aureus

Healthcare workers serve as vector for MRSA transmission in nursing home settings

DigiPath, Euphoria partner to set highest medical marijuana patient safety and education standards

Roche announces FDA clearance for cobas Cdiff Test to detect C. difficile in stool specimens

Bathing patients in common hospital soap can reduce MRSA contamination

Fecal transplantation cures C. diff infection, eliminates multi-drug resistant pathogens

New device can turn smartphone into DNA-scanning fluorescent microscope

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News